NCT05041673View on ClinicalTrials.gov

Anti-diabetic Drugs and Fatty Liver Management

NAUnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2022

Conditions

Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2

Interventions

DRUG

Metformin

Antidiabetic drugs

Trial Locations (1)

21131

Alexandria University., Alexandria

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Eva Pharma

INDUSTRY

lead

Alexandria University

OTHER